• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, Deerfield, IL

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 3 of 3

  • Page:
  • 1

Long-term Comparative Efficacy of Inebilizumab in the AQP4+ Subpopulation from N-MOmentum Open-label Period Versus Azathioprine and Immunosuppressants and Versus Placebo in Patients with NMOSD

Author:Cree, Bruce   Suero, Beatrice   Walsh, Sarah   Marignier, Romain   Lindsey, John   Kim, Ho Jin   She, Dewei   Cimbora, Daniel   Patterson, Kristina   Paul, Friedemann   

Session Name:S32: Autoimmune Neurology: NMOSD/MOGAD  

Topic:Autoimmune Neurology  

Program Number:S32.001  

Author Institution:Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA, San Francisco,, CA  Eversana, Burlington, Ontario, Canada, Burlington, ON, Canada  Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuroinflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France, Lyon, France  Division of Multiple Sclerosis and Neuroimmunology, University of Texas Health Science Center at Houston, Houston, TX, USA, Houston, TX  Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea, Goyang, Korea, Republic of  Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, Deerfield, IL  Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universita¨t Berlin and Humboldt-Universita¨t zu Berlin, Berlin, Germany, Berlin, Germany  

  • View Abstract
  • View Disclosure

Association of Cytokine Proteins with Disease Activity in Neuromyelitis Optica Spectrum Disorder Participants Receiving Inebilizumab Treatment

Author:Pittock, Sean   Aktas, Orhan   Kim, Ho Jin   Marignier, Romain   Wingerchuk, Dean   Smith, Micheal   Clarkson, Kristen   Rees, William   Patterson, Kristina   Cree, Bruce   

Session Name:S32: Autoimmune Neurology: NMOSD/MOGAD  

Topic:Autoimmune Neurology  

Program Number:S32.005  

Author Institution:Mayo Clinic and Center for MS and Autoimmune Neurology, Rochester, MN, USA, Rochester, MN  Medical Facility, Heinrich Heine University Du¨sseldorf, Du¨sseldorf, Germany, Düsseldorf, Germany  Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea, Goyang, Korea, Republic of  Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuroinflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France, Lyon, France  Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA , Scottsdale, AZ  Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, Rockville, MD  Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, Deerfield, IL  Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA, San Francisco, CA  

  • View Abstract
  • View Disclosure

Matching-adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-term Effectiveness

Author:Paul, Friedemann   Aktas, Orhan   Pedersen, Mikkel   Sorio-Vilela, Francesc   Patterson, Kristina   Rampal, Nishi   Cimbora, Daniel   Cree, Bruce   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.006  

Author Institution:Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany  Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany, Düsseldorf, Germany  EY Economics, Frederikssberg, Denmark, Frederikssberg, Denmark  Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, Zug, Switzerland  Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, Deerfield, IL  Amgen Research, Amgen Inc, Thousand Oaks, CA, USA, New Haven, CT  Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA, San Francisco, CA  

  • View Abstract
  • View Disclosure

Displaying 1 - 3 of 3

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com